Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02766374 · ClinicalTrials.gov registry record · NA
Heart Rate Variability Biofeedback: It's Role in Asthma Therapeutics
A NA study of Asthma, sponsored by Fred Wamboldt, MD.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 2
- Study locations
NCT02766374: Completed NA study of Asthma, sponsored by Fred Wamboldt, MD.
NCT02766374 is a NA study of Asthma that has completed, run by Fred Wamboldt, MD. The registered enrollment target is 68 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02766374, a NA study of Asthma, has completed, sponsored by Fred Wamboldt, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this research study to see whether biofeedback therapy helps treat asthma, and if so, how it works. Biofeedback is a treatment method that can teach how to bodily control. Biofeedback is widely used to help people relax. In this study however, the investigators want to learn if a specific type of biofeedback actually improves asthma in a way that might allow the reduction or elimination of other controller treatments like inhaled-corticosteroids.
Primary Outcome
Change in PEC20FEV1 measured after biofeedback from the PC20FEV1 measured at baseline
Conditions Studied
Interventions
- BEHAVIORAL Placebo
- BEHAVIORAL Heart rate variability biofeedback
Study Locations (2)
Colorado
- National Jewish Health - Denver
New Jersey
- Rutgers Robert Wood Johnson Medical School - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2009-12 |
| Est. Completion | 2018-01 |
| Phase | NA |
What the finished NCT02766374 record still lists
NCT02766374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02766374 reports a single indexed study location in Colorado, New Jersey.
Frequently Asked Questions
What is clinical trial NCT02766374 about?
NCT02766374 is a clinical study titled "Heart Rate Variability Biofeedback: It's Role in Asthma Therapeutics". The goal of this research study to see whether biofeedback therapy helps treat asthma, and if so, how it works. Biofeedback is a treatment method that can teach how to bodily control. Biofeedback is widely used to help people relax. In this study however, the investigators want to learn if a specifi...
What is the current status of trial NCT02766374?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2009-12. Estimated completion is 2018-01.
What conditions does trial NCT02766374 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT02766374?
The interventions under investigation include: Placebo (BEHAVIORAL), Heart rate variability biofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT02766374?
This trial is sponsored by Fred Wamboldt, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02766374 being conducted?
This trial has 2 study locations across Colorado, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02766374's enrollment target sits among peer trials
68 244th of 374 higher than 131 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia